National Institute for Health and Care Excellence

A part of the National Health Service, also called NICE

Before 1st April 2013, NICE was called the National Institute for Health and Clinical Excellence.

109 requests
Make a request to this authority
NICE agreements with three external parties
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Awaiting classification.

Dear Till Reference No: EH-302768 FREEDOM OF INFORMATION (FOI) ACT 2000 Thank you for your request, sent to our office on 9 November 2019, in wh...
15 documents related to multiple NICE appraisals
Request to National Institute for Health and Care Excellence by Till Bruckner. Annotated by Till Bruckner on .

Successful.

NICE provided the request files in .zip format. My Scribd page does not allow .zip uploads, so I did not place them online. If you would like to access...
Temporary agency non clinical spend
Response by National Institute for Health and Care Excellence to Helen Whitfield on .

Successful.

Dear Helen, Reference No: EH-302719-L8N7H6 FREEDOM OF INFORMATION ACT 2000 Thank you for contacting the National Institute for Health and Care Excellen...
Checklists of Confidential Information from manufacturer submissions for 154 appraisals
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Awaiting response.

Dear Till Reference no: EH-303095 FREEDOM OF INFORMATION ACT 2000 Thank you for your request, sent to our office on 21 November 2019, in which you a...
NICE redactions - communications linked to five previous FOIs
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Awaiting response.

Dear Till Reference no: EH-303098 FREEDOM OF INFORMATION ACT 2000 Thank you for your request, sent to our office on 21 November 2019, in which you a...
NICE CDF documents missing
Response by National Institute for Health and Care Excellence to Hiral Shah on .

Successful.

Dear Hiral,   Reference No: EH-303043   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on Tuesday 19 Nove...
Redacted data in TA 316 Enzalutamide for metastatic hormone‑relapsed prostate cancer
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Refused.

Dear Till   Reference No: EH-302040   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health and Care...
Redacted data in TA 445 Certolizumab pegol and secukinumab for treating active psoriatic arthritis
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Refused.

Dear Till   Reference No: EH-302038   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health and Care...
Redacted data in TA 238 Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Refused.

Dear Till   Reference No: EH-302039   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health and Care...
Checklists of Confidential Information from manufacturer submissions for 263 appraisals
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Refused.

Dear Till Reference No: EH-302041 FREEDOM OF INFORMATION (FOI) ACT 2000 Thank you for your request, sent to our office on 15 October 2019, in wh...
Intranet Queries
Response by National Institute for Health and Care Excellence to Louis James on .

Awaiting classification.

Dear Louis   Reference No: EH-302280-B7G9Y3   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health...
Data from the TA155 Ranibizumab and pegaptanib assessment report
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Refused.

Dear Till,   Reference No: EH-301743-C1H7B4   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health...
TA99. Immunosuppressive therapy for renal transplantation in children and adolescents
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Partially successful.

Dear Till,   Reference No: EH-301744-R4C7W6   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health...
Redacted information relating to TA 259 Abiraterone for metastatic prostate cancer
Response by National Institute for Health and Care Excellence to Till Bruckner on .

Refused.

Dear Till,   Reference No: EH-301745-V6F2J8   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health...
Staffing numbers
Response by National Institute for Health and Care Excellence to A Miller on .

Successful.

Dear Sir/Madam,   Reference No: EH105338   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health and...
Vaccines and side affects
Response by National Institute for Health and Care Excellence to Georgios Christodoulou on .

Information not held.

Dear Mr Christodoulou,   Reference No: EH-301427   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on Wedn...
NICE SERNIP TOT, TVOT Safety and Efficacy
Response by National Institute for Health and Care Excellence to Julie Loxley on .

Successful.

Dear Ms Loxley,   Reference No: EH104065   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 12 May 2019,...
Software systems
Response by National Institute for Health and Care Excellence to Conor McClean on .

Successful.

Dear Conor,   Reference No: EH107058   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health and Car...
NICE correspondence relating to US-UK Trade Deals
Response by National Institute for Health and Care Excellence to Laura Hendry on .

Information not held.

Dear Laura,   Reference No: EH106723   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health and Car...
Exact figures behind those used in'Intrapartum care for healthy women and babies'
Response by National Institute for Health and Care Excellence to Timothy Watson on .

Successful.

Dear Tim,   Reference No: EH106198   FREEDOM OF INFORMATION ACT 2000   Thank you for contacting the National Institute for Health and Care...
Rigevidon
Response by National Institute for Health and Care Excellence to Laura Hanton on .

Information not held.

Dear Laura   Reference No: EH101689   FREEDOM OF INFORMATION ACT 2000   Thank you for your request for information, received at this office...
Montelukast Warning
Response by National Institute for Health and Care Excellence to gabrielle teare on .

Information not held.

Dear Ms Teare,   Reference No: EH105768   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 13 July 2019,...
Haemotherapy
Response by National Institute for Health and Care Excellence to michael price on .

Awaiting classification.

Dear Michael,   The link that was referred to in answer to question 3 of your request for information was to our guideline on [1]blood transfusion...
Overall survival data for breast cancer drug Palbociclib
Response by National Institute for Health and Care Excellence to Debra Winberg on .

Successful.

Dear Ms Winberg,   Reference No: EH103832   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 4 May 2019,...
Pelvic Mesh - SERNIP
Response by National Institute for Health and Care Excellence to Julie Loxley on .

Awaiting classification.

Dear Ms Loxley,   Reference No: EH104068   FREEDOM OF INFORMATION ACT 2000   Thank you for your request, sent to our office on 12 May 2019,...

Only requests made using WhatDoTheyKnow are shown. ?